Matches in Nanopublications for { <http://www.nextprot.org/nanopubs#NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._1> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._1 type RangedSequencePosition NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g.assertion.
- NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._1 type SO_0001148 NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g.assertion.
- NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._1 comment "Abolishes interaction with the apo LBD of RARA. No change on interaction on the addition of inverse agonist BMS493." NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g.assertion.
- NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._1 SIO_000053 NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._3 NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g.assertion.
- NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._1 SIO_000053 NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g._2 NX_Q9Y618-3_MUTAGEN_2133_2133.RAppn7WYvgOJD0WfB3PvDNVo6dpJ0Ws8pe3wWXqMr3O4g.assertion.